Opiant Pharmaceuticals Inc (OPNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 01-2016 | 10-2015 | 07-2015 | 04-2015 | 01-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,140 | -11,110 | N/A | -5,402 | -3,551 |
| Depreciation Amortization | 1 | 0 | N/A | 1 | 1 |
| Accounts payable and accrued liabilities | -280 | -208 | N/A | -125 | -123 |
| Other Working Capital | -3,840 | 83 | N/A | 690 | 547 |
| Other Operating Activity | 10,903 | 10,487 | 0 | 1,751 | 752 |
| Operating Cash Flow | $-356 | $-748 | $N/A | $-3,084 | $-2,374 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 151 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 1,052 | 769 | 0 | 4,169 | 3,181 |
| Financing Cash Flow | $1,204 | $769 | $N/A | $4,169 | $3,181 |
| Beginning Cash Position | 434 | 434 | N/A | 255 | 255 |
| End Cash Position | 1,282 | 455 | N/A | 1,339 | 1,061 |
| Net Cash Flow | $847 | $21 | $N/A | $1,085 | $806 |
| Free Cash Flow | |||||
| Operating Cash Flow | -356 | -748 | N/A | -3,084 | -2,374 |
| Free Cash Flow | -356 | -748 | 0 | -3,084 | -2,374 |